BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1936805)

  • 1. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
    Kaplan MM; Knox TA
    Gastroenterology; 1991 Nov; 101(5):1332-8. PubMed ID: 1936805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methotrexate in the therapy of primary biliary cirrhosis].
    Weber P; Scheurlen M; Wiedmann KH
    Dtsch Med Wochenschr; 1991 Sep; 116(36):1347-52. PubMed ID: 1884674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.
    Wiesner RH; Ludwig J; Lindor KD; Jorgensen RA; Baldus WP; Homburger HA; Dickson ER
    N Engl J Med; 1990 May; 322(20):1419-24. PubMed ID: 2184355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.
    Kaplan MM; Schmid C; Provenzale D; Sharma A; Dickstein G; McKusick A
    Gastroenterology; 1999 Nov; 117(5):1173-80. PubMed ID: 10535881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary biliary cirrhosis treated with low-dose oral pulse methotrexate.
    Kaplan MM; Knox TA; Arora SA
    Ann Intern Med; 1988 Sep; 109(5):429-31. PubMed ID: 3408057
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment.
    Kaplan MM; DeLellis RA; Wolfe HJ
    Ann Intern Med; 1997 May; 126(9):682-8. PubMed ID: 9139553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for primary biliary cirrhosis.
    Giljaca V; Poropat G; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2010 May; (5):CD004385. PubMed ID: 20464729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary biliary cirrhosis (PBC): is effective therapy now at hand?
    Kaplan MM; Knox TA; Arora S
    Trans Assoc Am Physicians; 1988; 101():193-202. PubMed ID: 3269678
    [No Abstract]   [Full Text] [Related]  

  • 13. Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone.
    Buscher HP; Zietzschmann Y; Gerok W
    J Hepatol; 1993 Apr; 18(1):9-14. PubMed ID: 8101853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis.
    Quarneti C; Muratori P; Lalanne C; Fabbri A; Menichella R; Granito A; Masi C; Lenzi M; Cassani F; Pappas G; Muratori L
    Liver Int; 2015 Feb; 35(2):636-41. PubMed ID: 24698666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary sclerosing cholangitis with oral methotrexate.
    Knox TA; Kaplan MM
    Am J Gastroenterol; 1991 May; 86(5):546-52. PubMed ID: 2028943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bezafibrate for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up.
    Hwang SJ; Chan CY; Lee SD; Wu JC; Tsay SH; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(3):217-23. PubMed ID: 8100153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial.
    Hendrickse MT; Rigney E; Giaffer MH; Soomro I; Triger DR; Underwood JC; Gleeson D
    Gastroenterology; 1999 Aug; 117(2):400-7. PubMed ID: 10419922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.